Free Trial

Northwest & Ethical Investments L.P. Increases Stock Holdings in Genpact Limited (NYSE:G)

Genpact logo with Business Services background
Remove Ads

Northwest & Ethical Investments L.P. boosted its holdings in Genpact Limited (NYSE:G - Free Report) by 5.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 304,582 shares of the business services provider's stock after buying an additional 14,416 shares during the quarter. Northwest & Ethical Investments L.P. owned approximately 0.17% of Genpact worth $13,082,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Teacher Retirement System of Texas bought a new stake in shares of Genpact during the fourth quarter worth about $3,186,000. Harvest Fund Management Co. Ltd bought a new stake in Genpact during the 4th quarter worth approximately $188,000. Xponance Inc. increased its position in Genpact by 8.0% in the 4th quarter. Xponance Inc. now owns 19,566 shares of the business services provider's stock valued at $840,000 after acquiring an additional 1,454 shares during the period. Intech Investment Management LLC bought a new position in shares of Genpact during the fourth quarter valued at $5,783,000. Finally, Signaturefd LLC grew its stake in shares of Genpact by 11.4% in the fourth quarter. Signaturefd LLC now owns 19,021 shares of the business services provider's stock worth $817,000 after purchasing an additional 1,952 shares during the last quarter. Institutional investors own 96.03% of the company's stock.

Genpact Stock Up 0.1 %

NYSE:G traded up $0.03 during trading hours on Monday, reaching $49.93. The company had a trading volume of 1,282,727 shares, compared to its average volume of 1,296,078. The business's 50-day simple moving average is $50.27 and its two-hundred day simple moving average is $44.70. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $56.76. The firm has a market cap of $8.77 billion, a price-to-earnings ratio of 17.58, a P/E/G ratio of 1.84 and a beta of 1.16. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.

Remove Ads

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. On average, equities analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.36%. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio (DPR) is presently 23.94%.

Analyst Ratings Changes

Several brokerages have commented on G. Mizuho lifted their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and increased their target price for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Needham & Company LLC boosted their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, Genpact presently has a consensus rating of "Hold" and an average price target of $48.44.

View Our Latest Analysis on Genpact

Insider Buying and Selling at Genpact

In other news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. The trade was a 4.20 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads